Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 9.849M
March 31, 2026 10.43M
December 31, 2025 11.37M
September 30, 2025 13.14M
June 30, 2025 16.22M
March 31, 2025 14.90M
December 31, 2024 14.14M
September 30, 2024 15.11M
June 30, 2024 13.98M
March 31, 2024 20.05M
December 31, 2023 17.62M
September 30, 2023 14.68M
June 30, 2023 14.22M
March 31, 2023 13.91M
Date Value
December 31, 2022 13.72M
September 30, 2022 13.90M
June 30, 2022 0.00
March 31, 2022 14.69M
December 31, 2021 7.726M
September 30, 2021 7.466M
June 30, 2021 5.828M
March 31, 2021 7.121M
December 31, 2020 4.927M
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019 1.722M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Autolus Therapeutics Plc 418.39M
Cellectis SA 226.30M
Akari Therapeutics Plc 20.03M
DBV Technologies SA 62.80M
argenx SE --

Total Liabilities (Quarterly) Related Metrics